Strs Ohio Care Dx, Inc. Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Care Dx, Inc. stock. As of the latest transaction made, Strs Ohio holds 40,000 shares of CDNA stock, worth $1.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,000

Previous 51,100 21.72%

Holding current value

$1.19 Million

Previous $541,000 14.79%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$7.56 - $16.15 $83,916 - $179,264	-11,100 Reduced 21.72%	40,000 $621,000
Q1 2024 May 13, 2024	SELL	$7.96 - $12.37 $73,232 - $113,804	-9,200 Reduced 15.26%	51,100 $541,000
Q4 2023 Jan 30, 2024	BUY	$4.9 - $12.86 $116,620 - $306,068	23,800 Added 65.21%	60,300 $723,000
Q3 2023 Oct 26, 2023	BUY	$7.0 - $11.26 $22,400 - $36,032	3,200 Added 9.61%	36,500 $255,000
Q2 2023 Jul 31, 2023	BUY	$7.61 - $9.46 $19,786 - $24,596	2,600 Added 8.47%	33,300 $283,000
Q1 2023 Aug 02, 2023	SELL	$8.83 - $17.61 $22,958 - $45,786	-2,600 Reduced 7.81%	30,700 $280,000
Q2 2022 Jul 25, 2022	BUY	$20.49 - $39.72 $508,151 - $985,056	24,800 Added 420.34%	30,700 $659,000
Q3 2021 Oct 22, 2021	SELL	$59.15 - $91.99 $307,580 - $478,348	-5,200 Reduced 46.85%	5,900 $373,000
Q2 2021 Jul 26, 2021	BUY	$63.02 - $95.11 $12,604 - $19,022	200 Added 1.83%	11,100 $1.02 Million
Q4 2020 Jan 25, 2021	BUY	$41.43 - $77.09 $451,587 - $840,281	10,900 New	10,900 $789,000
Q4 2018 Jan 23, 2019	SELL	$19.89 - $30.02 $0 - $0	0 Closed	0 $0
Q3 2018 Oct 19, 2018	SELL	$12.1 - $28.85 $114,950 - $274,075	-9,500 Closed	0 $0
Q2 2018 Aug 06, 2018	BUY	$7.93 - $15.79 $75,335 - $150,005	9,500 New	9,500 $116,000

Others Institutions Holding CDNA

# of Institutions

157

Shares Held

53.5M

Call Options Held

60.8K

Put Options Held

34.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $1.59B
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account